Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardl...

Por Weng, Wen-Kai, Czerwinski, Debra, Levy, Ronald
Publicado em 2007

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells

Por Irish, Jonathan M., Czerwinski, Debra K., Nolan, Garry P., Levy, Ronald
Publicado em 2006

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors

Por Brody, Joshua D., Goldstein, Matthew J., Czerwinski, Debra K., Levy, Ronald
Publicado em 2009

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

Por Ai, Weiyun Z., Tibshirani, Robert, Taidi, Behnaz, Czerwinski, Debra, Levy, Ronald
Publicado em 2009

Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma

Por Sagiv-Barfi, Idit, Kohrt, Holbrook E., Burckhardt, Laura, Czerwinski, Debra K., Levy, Ronald
Publicado no Blood (2015)

Follicular lymphoma B cells induce the conversion of conventional CD4(+) T cells to T regulatory cells

Por Ai, Weiyun Z., Hou, Jing-Zhou, Zeiser, Robert, Czerwinski, Debra, Negrin, Robert S., Levy, Ronald
Publicado em 2009

Eradication of spontaneous malignancy by local immunotherapy

Por Sagiv-Barfi, Idit, Czerwinski, Debra K., Levy, Shoshana, Alam, Israt S., Mayer, Aaron T., Gambhir, Sanjiv S., Levy, Ronald
Publicado no Sci Transl Med (2018)

Generation of CD8(+) T cell–mediated immunity against idiotype-negative lymphoma escapees

Por Varghese, Bindu, Widman, Adam, Do, James, Taidi, Behnaz, Czerwinski, Debra K., Timmerman, John, Levy, Shoshana, Levy, Ronald
Publicado em 2009

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

Por Sagiv-Barfi, Idit, Kohrt, Holbrook E. K., Czerwinski, Debra K., Ng, Patrick P., Chang, Betty Y., Levy, Ronald
Publicado no Proc Natl Acad Sci U S A (2015)

A CpG-loaded tumor cell vaccine induces antitumor CD4(+) T cells that are effective in adoptive therapy for large and established tumors

Por Goldstein, Matthew J., Varghese, Bindu, Brody, Joshua D., Rajapaksa, Ranjani, Kohrt, Holbrook, Czerwinski, Debra K., Levy, Shoshana, Levy, Ronald
Publicado em 2011

T-cell immunopeptidomes reveal cell subtype surface markers derived from intracellular proteins

Por Olsson, Niclas, Schultz, Liora M, Zhang, Lichao, Khodadoust, Michael S., Narayan, Rupa, Czerwinski, Debra K., Levy, Ronald, Elias, Joshua E.
Publicado no Proteomics (2018)

CD81 is a novel immunotherapeutic target for B cell lymphoma

Por Vences-Catalán, Felipe, Kuo, Chiung-Chi, Rajapaksa, Ranjani, Duault, Caroline, Andor, Noemi, Czerwinski, Debra K., Levy, Ronald, Levy, Shoshana
Publicado no J Exp Med (2019)

Downregulation of Protein 4.1R, a Mature Centriole Protein, Disrupts Centrosomes, Alters Cell Cycle Progression, and Perturbs Mitotic Spindles and Anaphase

Por Krauss, Sharon Wald, Spence, Jeffrey R., Bahmanyar, Shirin, Barth, Angela I. M., Go, Minjoung M., Czerwinski, Debra, Meyer, Adam J.
Publicado em 2008

Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation

Por Kohrt, Holbrook E., Müller, Antonia, Baker, Jeanette, Goldstein, Matthew J., Newell, Evan, Dutt, Suparna, Czerwinski, Debra, Lowsky, Robert, Strober, Samuel
Publicado em 2011

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

Por Timmerman, John M., Vose, Julie M., Czerwinski, Debra K., Weng, Wen-Kai, Ingolia, Diane, Mayo, Martha, Denney, Dan W., Levy, Ronald
Publicado em 2009

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression

Por Irish, Jonathan M., Myklebust, June H., Alizadeh, Ash A., Houot, Roch, Sharman, Jeff P., Czerwinski, Debra K., Nolan, Garry P., Levy, Ronald
Publicado em 2010

Imaging activated T cells predicts response to cancer vaccines

Por Alam, Israt S., Mayer, Aaron T., Sagiv-Barfi, Idit, Wang, Kezheng, Vermesh, Ophir, Czerwinski, Debra K., Johnson, Emily M., James, Michelle L., Levy, Ronald, Gambhir, Sanjiv S.
Publicado no J Clin Invest (2018)

Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin

Por Narayan, Rupa, Olsson, Niclas, Wagar, Lisa E., Medeiros, Bruno C., Meyer, Everett, Czerwinski, Debra, Khodadoust, Michael S., Zhang, Lichao, Schultz, Liora, Davis, Mark M., Elias, Joshua E., Levy, Ron
Publicado no PLoS One (2019)

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

Por Mueller, Antonia MS, Hebb, Jonathan, Sagiv-Barfi, Idit, Marabelle, Aurelien, Houot, Roch, Rajapaksa, Amanda, Czerwinski, Debra K, Chang, Serena, Chester, Cariad, Sadaram, Mohith, Waller, Erin, Levy, Ronald, Kohrt, Holbrook
Publicado no J Immunother Cancer (2014)

CANCER VACCINES AND T CELL THERAPY

Por Rezvani, Katayoun, Brody, Joshua D., Kohrt, Holbrook E., Logan, Aaron C., Advani, Ranjana, Czerwinski, Debra Katherine, Weng, Wen-Kai, Negrin, Robert S., Carlton, Victoria, Faham, Malek, Levy, Ronald, Barrett, John
Publicado no Biol Blood Marrow Transplant (2012)